G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms
PJ Bates, EM Reyes-Reyes, MT Malik… - … et Biophysica Acta (BBA …, 2017 - Elsevier
Background AS1411 is a 26-mer G-rich DNA oligonucleotide that forms a variety of G-
quadruplex structures. It was identified based on its cancer-selective antiproliferative activity …
quadruplex structures. It was identified based on its cancer-selective antiproliferative activity …
New perspectives of physiological and pathological functions of nucleolin (NCL)
W Jia, Z Yao, J Zhao, Q Guan, L Gao - Life sciences, 2017 - Elsevier
Nucleolin (NCL) is a multifunctional protein that mainly localized in the nucleolus, it is also
found in the nucleoplasm, cytoplasm and cell membrane. The three main structural domains …
found in the nucleoplasm, cytoplasm and cell membrane. The three main structural domains …
Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma
MA Taylor, BC Das, SK Ray - Apoptosis, 2018 - Springer
Autophagy is an evolutionarily conserved catabolic process that plays an essential role in
maintaining cellular homeostasis by degrading unneeded cell components. When exposed …
maintaining cellular homeostasis by degrading unneeded cell components. When exposed …
Nucleolin-based targeting strategies for cancer therapy: from targeted drug delivery to cytotoxic ligands
S Romano, N Fonseca, S Simoes, J Goncalves… - Drug Discovery …, 2019 - Elsevier
Highlights•Nucleolin is overexpressed at the surface cancer cells and tumor
vasculature.•Nucleolin enables dual cellular targeting strategies.•Surface nucleolin as a …
vasculature.•Nucleolin enables dual cellular targeting strategies.•Surface nucleolin as a …
[HTML][HTML] Roles of nucleolin: Focus on cancer and anti-cancer therapy
Z Chen, XH Xu - Saudi medical journal, 2016 - ncbi.nlm.nih.gov
Nucleolin, a multifunctional protein distributed in the nucleolus, participates in many
modulations including rDNA transcription, RNA metabolism, and ribosome assembly …
modulations including rDNA transcription, RNA metabolism, and ribosome assembly …
Iron oxide nanoparticles as carriers for DOX and magnetic hyperthermia after intratumoral application into breast cancer in mice: impact and future perspectives
S Piehler, H Dähring, J Grandke, J Göring, P Couleaud… - Nanomaterials, 2020 - mdpi.com
There is still a need for improving the treatment of breast cancer with doxorubicin (DOX). In
this paper, we functionalized magnetic nanoparticles (MNPs) with DOX and studied the DOX …
this paper, we functionalized magnetic nanoparticles (MNPs) with DOX and studied the DOX …
Fabrication of aptamer-guided siRNA loaded lipopolyplexes for gene silencing of notch 1 in MDA-mb-231 triple negative breast cancer cell line
L Gharaibeh, W Alshaer, S Wehaibi, R Al Buqain… - Journal of Drug Delivery …, 2021 - Elsevier
Triple negative breast cancer is an aggressive type of cancer with limited therapeutic
options. Aptamer-functionalized liposomes to deliver short interference RNAs (siRNAs) offer …
options. Aptamer-functionalized liposomes to deliver short interference RNAs (siRNAs) offer …
AS1411-induced growth inhibition of glioma cells by up-regulation of p53 and down-regulation of Bcl-2 and Akt1 via nucleolin
Y Cheng, G Zhao, S Zhang, F Nigim, G Zhou, Z Yu… - PLoS …, 2016 - journals.plos.org
AS1411 binds nucleolin (NCL) and is the first oligodeoxynucleotide aptamer to reach phase
I and II clinical trials for the treatment of several cancers. However, the mechanisms by which …
I and II clinical trials for the treatment of several cancers. However, the mechanisms by which …
Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation
Pancreatic cancer remains one of the deadliest human cancers despite current advances in
conventional therapeutics including surgery and adjuvant therapies. Here, we showed that …
conventional therapeutics including surgery and adjuvant therapies. Here, we showed that …
Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy
S Thongchot, K Aksonnam… - International …, 2023 - spandidos-publications.com
The benefits of treating several types of cancers using immunotherapy have recently been
established. The overexpression of nucleolin (NCL) in a number of types of cancer provides …
established. The overexpression of nucleolin (NCL) in a number of types of cancer provides …